Determining optimal timing of birth for women with chronic or gestational hypertension at term: the WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial
<p><b>Background</b></p> Chronic or gestational hypertension complicates approximately 7% of pregnancies, half of which reach 37 weeks’ gestation. Early term birth (at 37 to 38 weeks) may reduce maternal complications, cesareans, stillbirths, and costs but may increase neonat...
Main Authors: | Magee, LA, Kirkham, K, Tohill, S, Gkini, E, Moakes, CA, Dorling, J, Green, M, Hutcheon, JA, Javed, M, Kigozi, J, Mol, BWM, Singer, J, Hardy, P, Stubbs, C, Thornton, JG, von Dadelszen, P, WILL Trial Study Group |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2024
|
Similar Items
-
Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial.
by: Laura A Magee, et al.
Published: (2024-11-01) -
WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial — adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic
by: Laura A. Magee, et al.
Published: (2022-10-01) -
Labor induction information leaflets—Do women receive evidence-based information about the benefits and harms of labor induction?
by: Peter von Dadelszen, et al.
Published: (2022-11-01) -
Management of Hypertension in Pregnancy
by: Laura A. Magee, et al.
Published: (2021-04-01) -
Placental growth factor as a prognostic tool in women with Hypertensive disorders of pregnancy: A systematic review..
by: Ukah, UV, et al.
Published: (2017)